Omniox

a biotechnology company, commercializes technologies used in identifying and treating cancer, cardiovascular disease and trauma

Omniox is a business in health based in Silicon Valley, California, founded in 2006.

Profile

Omniox is a pioneering biotechnology company specializing in commercializing a revolutionary oxygen delivery technology for various clinical indications in cancer, surgical, and cardiovascular fields. Founded to translate groundbreaking biotherapeutic platforms developed at the University of California, Berkeley, Omniox's innovative approach stems from the expertise of Professor Michael A. Marletta and his team of exceptional scientists. Their proprietary oxygen delivery vehicles offer unique properties that can be harnessed for a wide range of clinical applications, making significant strides in the treatment of cancer, cardiovascular disease, and trauma. Omniox's commitment to advancing healthcare through cutting-edge technologies underscores its importance in driving innovation and improving patient outcomes in the medical industry.

Within the health space, the company focuses on its core offering rather than a broad product line.

The business is associated with Silicon Valley, California.

Directory data places it at the Plug and Play portfolio startup stage.

Recorded headcount: 1-10 employees.

Website: www.omniox.com